Evidence map›Paper›PMID 12959216›Full record

ReviewJournal of clinical immunology2003

Immunoglobulin somatic hypermutation: double-strand DNA breaks, AID and error-prone DNA repair.

Xiaoping Wu, Junli Feng, Atsumasa Komori, Edmund C Kim, Hong Zan, Paolo Casali

Abstract readReview
In one paragraph

Review in Journal of clinical immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoping WuDivision of Molecular Immunology, Joan and Sanford I. Weill Medical College and Graduate School of Medical Sciences, Cornell University, New York, USA.
Junli Feng
Atsumasa Komori
Edmund C Kim
Hong Zan
Paolo Casali
Cornell University · USUniversity of California, Irvine · US

Funding

Immunoglobulin class switch DNA recombinationR01AI045011 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 2000 to 2011
$3.8M
SOMATIC HYPERMUTATION IN HUMAN B CELLSR01AR040908 · NIAMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 1992 to 2005
$1.8M
AGING--ANTIBODY RESPONSE TO BACTERIAL AND VIRAL AGSR01AG013910 · NIA · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 1997 to 2001
$687k
Immunoglobulin class switch DNA recombinationR56AI045011 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2012 to 2012
$523k
BIOLOGICAL AND MOLECULAR STUDY OF THE GENE PRODUCT OF THE CCR5DELTA32 ALLELEZ01AI000762 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI SCALA, G · 1997 to 1998
–
NIAID NIH HHS AI 0762NIAID NIH HHS AI 45011NIAID NIH HHS R01 AI045011NIAID NIH HHS R56 AI045011NIAMS NIH HHS AR 40908NIAMS NIH HHS R01 AR040908NIA NIH HHS AG 13910
6 · The paper itself

Abstract

Somatic hypermutation (SHM) is critical for antibody affinity maturation and the generation of memory B cells. Somatic mutations consist mainly of single nucleotide changes with rare insertions and deletions. Such changes would be introduced during error-prone repair of lesions involving single-strand DNA breaks (SSBs) or, more likely, double-strand DNA breaks (DSBs), as DSBs occur exclusively in genes that have the potentials to undergo SHM. In the human, such genes include Ig V, BCL6, and c-MYC. In these germline genes, DSBs are blunt. In rearranged Ig V, BCL6, and translocated c-MYC genes, blunt DSBs are processed to yield resected DNA ends. This process is dependent on the expression of activation-induced cytidine deaminase (AID), which is selectively expressed upon CD40-signaling in hypermutating B cells. CD40-induced and AID-dependent free 5'- and 3'-staggered DNA ends critically channel the repair of DSBs through the homologous recombination (HR) repair pathway. During HR, the modulation of critical translesion DNA polymerases, as signaled by cross-linking of the B cell receptor (BCR) for antigen, leads to the insertions of mismatches, i.e., mutations. The nature of DSBs, the possible roles of AID in the modification of DSBs and that of the translesion DNA polymerases zeta and iota in the subsequent repair process that lead to the insertions of mutations are discussed here within the context of an integrated model of SHM.

Indexed as

DNA DamageDNA RepairSomatic Hypermutation, ImmunoglobulinAICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCytidine DeaminaseDNADNA-Binding ProteinsHumansAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDNADNA-Binding Proteins

Identifiers

PMID12959216
PMCPMC4624321
OpenAlexW10737317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.